Latest filing published 14 Oct 2022 for Forma Therapeutics Holdings, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Brian Andrew Lesser, listed as senior executive, appears in our data through filings on Forma Therapeutics Holdings, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 23 February 2022 and the latest from 14 October 2022.
On the market, this insider has only sold: 1 sale, €33k in total. The rest of the record consists of 1 share grant.
The record was last updated on 14 October 2022 with a transaction in Forma Therapeutics Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations